NSB 7.69% 3.6¢ neuroscientific biopharmaceuticals ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,549 Posts.
    lightbulb Created with Sketch. 298
    Assuming continual spend, they'll be down to around $6m in the kitty at the end of March. What's the feeling on a CR before phase 1 trials?

    Dr. Andrews has mentioned in a recent interview that they won't need it but it may be too good to refuse some extra cash before some decent news flow.

    Thoughts?
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
-0.003(7.69%)
Mkt cap ! $5.205M
Open High Low Value Volume
3.8¢ 3.8¢ 3.6¢ $1.413K 38.14K

Buyers (Bids)

No. Vol. Price($)
1 89720 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 75583 1
View Market Depth
Last trade - 15.05pm 13/11/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.